These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21881814)

  • 1. [Final height (FH) in Turner syndrome (TS): experience of 76 cases followed at the Pediatric Endocrinology Unit, Hospital de Clinicas, Federal University of Paraná].
    Fonteles AV; Dondoni RS; Boguszewski MC; Nesi-França S; Marques-Pereira R; Sandrini Neto R; Lacerda Filho Ld
    Arq Bras Endocrinol Metabol; 2011 Jun; 55(5):318-25. PubMed ID: 21881814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hormonal therapy on growth rate and bone age progression in patients with Turner syndrome.
    Gawlik A; Gawlik T; Koehler B; Malecka-Tendera E; Augustyn M; Woska W
    Endokrynol Pol; 2005; 56(2):136-44. PubMed ID: 16335681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome.
    Mohamed S; Alkofide H; Adi YA; Amer YS; AlFaleh K
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcome in Turner syndrome.
    Parvin M; Roche E; Costigan C; Hoey HM
    Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
    Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P; Massarano AA; Stanhope R
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
    Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
    Freriks K; Sas TC; Traas MA; Netea-Maier RT; den Heijer M; Hermus AR; Wit JM; van Alfen-van der Velden JA; Otten BJ; de Muinck Keizer-Schrama SM; Gotthardt M; Dejonckere PH; Zandwijken GR; Menke LA; Timmers HJ
    Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near normalization of final height with adapted doses of growth hormone in Turner's syndrome.
    Carel JC; Mathivon L; Gendrel C; Ducret JP; Chaussain JL
    J Clin Endocrinol Metab; 1998 May; 83(5):1462-6. PubMed ID: 9589639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.
    Sas TC; Gault EJ; Bardsley MZ; Menke LA; Freriks K; Perry RJ; Otten BJ; de Muinck Keizer-Schrama SM; Timmers H; Wit JM; Ross JL; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):289-97. PubMed ID: 24776783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth pattern and final height of girls with Turner syndrome with and without human growth hormone treatment.
    Dacou-Voutetakis C; Karavanaki-Karanassiou K; Petrou V; Georgopoulos N; Maniati-Christidi M; Mavrou A
    Pediatrics; 1998 Apr; 101(4 Pt 1):663-8. PubMed ID: 9521953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy in Turner syndrome.
    Davenport ML
    Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():723-4. PubMed ID: 22946284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height.
    Rosenfeld RG; Attie KM; Frane J; Brasel JA; Burstein S; Cara JF; Chernausek S; Gotlin RW; Kuntze J; Lippe BM; Mahoney CP; Moore WV; Saenger P; Johanson AJ
    J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of final height in girls with Turner syndrome treated with growth hormone].
    Morin A; Guimarey L; Santucci Z; Apezteguia M
    Medicina (B Aires); 2000; 60(5 Pt 1):551-4. PubMed ID: 11188890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.